As time goes by there are a lot of new things coming up in every industry. Improvements have been made in every corner of the world. Talk about how technology has led to new inventions in all fields may it be banking, traveling, how we pay our bills etcetera. The healthcare industry has not been left behind. Technology has been used in the healthcare industry to improve the efficiency of diagnosis, testing, and even treatment. Marc Beer has been associated mainly in the health industry for over 20years, 25 to be precise. Marc Beer experience stretches into biotechnology, devices, pharmaceuticals among others. He has played a part in creating, developing and also develops as a business in such areas of the health industry.
Marc Beer has taken a keen interest in the specific area of the health sector; where he seeks to help patients with a particular form of disorders. By investing in research of drugs that are used in therapy to help cure or alleviate their medical conditions. Marc Beer was at one time the strategic consultant to OvaScience. He also held some positions in Genzyme and also the vice of Global Marketing, he over sighted commercialization of line of drugs for rare disease treatment
In the recent past, Marc Beer raised $42M for a startup with the sole purpose of helping women with pelvic floor disorder. The startup goes by the name Renovia. Marc Beer founded Renovia alongside Ramon Iglesias and Yolanda Lorie back in August of the year 2016. Renovia has attracted the attention of The Longwood Fund which is a firm that invests in healthcare. Longwood made an early investment into Renovia. The funds will go a long way into testing and developing other products and some devices such as the Leva device.
Statistics show that over 250 million women are suffering from the disorder. A person suffering from pelvic floor disorder cannot control the pelvic floor muscles. The pelvic floor supports the organs of the pelvis; the bladder, rectum, uterus or prostate. It causes difficulty in bowel movements. When we talk about an initiative to curb such conditions, it means saving a lot of people from the pain. The Boston based medtech firm is developing diagnostic and therapeutic products. Among the pelvic floor disorders are urinary incontinence. Which as it is an embarrassment that might prove difficult to deal with in women. In the long term, Renovia will strive to find treatments, create awareness and inform people. They also aim at making treatment affordable to all sorts of people.
Marc Beer, a graduate of the Miami University with a bachelor of science degree sits on some boards and consulting roles in several companies. He is the chair for ERYtech Pharma. Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-